October 27, 2023
New York Governor Kathy Hochul has signed into law a bill that would restrict minors from purchasing dietary supplements marketed toward “weight loss and muscle building.”
October 20, 2023
Here’s what brands can likely expect from an updated Green Guides.
The ingredients are GlyCare 2’-fucosyllactose (2’-FL) and GlyCare lacto-N-neotetraose (LNnT).
October 19, 2023
The company’s Aequival 2’-FL is a human milk oligosaccharide ingredient that supports infants’ microbiome health.
October 17, 2023
The company recently notified FDA of the Generally Recognized as Safe (GRAS) status of its Pomella pomegranate extract. FDA responded with a letter of no objection.
October 13, 2023
An increasingly unwieldly cannabinoid industry may force Congress to take action on hemp-derived cannabinoid regulation.
October 10, 2023
The decision marks the first time HMOs has been approved by China for use in infant formula.
October 09, 2023
The spotlight on delta-8 THC is heating up. Where will regulators ultimately land in regard to this controversial cannabinoid?
October 06, 2023
PLT Health Solution has announced the receipt of an expanded license from the Natural and Non-Prescription Health Products Directorate (NNHPD) of Health Canada to market its AlvioLife ingredient for respiratory health support in Canada.
October 02, 2023
FTC’s Endorsement Guides got a critical update this year.